financetom
Business
financetom
/
Business
/
Gilead Sciences Insider Sold Shares Worth $340,710, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gilead Sciences Insider Sold Shares Worth $340,710, According to a Recent SEC Filing
Sep 16, 2025 2:53 PM

05:22 PM EDT, 09/16/2025 (MT Newswires) -- Johanna Mercier, Chief Commercial Officer, on September 15, 2025, sold 3,000 shares in Gilead Sciences ( GILD ) for $340,710. Following the Form 4 filing with the SEC, Mercier has control over a total of 113,193 common shares of the company, with 113,193 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/882095/000178213525000008/xslF345X05/wk-form4_1758057358.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Globus Medical Insider Sold Shares Worth $584,600, According to a Recent SEC Filing
Globus Medical Insider Sold Shares Worth $584,600, According to a Recent SEC Filing
Sep 16, 2025
05:22 PM EDT, 09/16/2025 (MT Newswires) -- Ann D Rhoads, Director, on September 15, 2025, sold 10,000 shares in Globus Medical ( GMED ) for $584,600. Following the Form 4 filing with the SEC, Rhoads has control over a total of 25,384 Class A common shares of the company, with 25,384 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1237831/000119312525205135/xslF345X05/ownership.xml ...
Kura Oncology Hosts Event Focused on Farnesyl Transferase Inhibitor Program
Kura Oncology Hosts Event Focused on Farnesyl Transferase Inhibitor Program
Sep 16, 2025
05:27 PM EDT, 09/16/2025 (MT Newswires) -- Kura Oncology ( KURA ) said Tuesday it is hosting the first of two events for analysts and investors focused on its farnesyl transferase inhibitor, or FTI, program. The event will feature preclinical data showing the potential of FTIs to improve the anti-tumor activity of targeted treatments in diverse tumor types, the company...
Lightwave Logic Extends CEO's Tenure Until 2028; Announces CFO, COO Retirement
Lightwave Logic Extends CEO's Tenure Until 2028; Announces CFO, COO Retirement
Sep 16, 2025
05:23 PM EDT, 09/16/2025 (MT Newswires) -- Lightwave Logic ( LWLG ) said late Tuesday its board and Chief Executive Yves LeMaitre have agreed to extend his employment term until the end of 2028. The electro-optic polymer materials company's Chief Financial Officer and Chief Operating Officer Jim Marcelli will also be retiring at the end of 2025. Lightwave said it...
Gilead Sciences Insider Sold Shares Worth $340,710, According to a Recent SEC Filing
Gilead Sciences Insider Sold Shares Worth $340,710, According to a Recent SEC Filing
Sep 16, 2025
05:22 PM EDT, 09/16/2025 (MT Newswires) -- Johanna Mercier, Chief Commercial Officer, on September 15, 2025, sold 3,000 shares in Gilead Sciences ( GILD ) for $340,710. Following the Form 4 filing with the SEC, Mercier has control over a total of 113,193 common shares of the company, with 113,193 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/882095/000178213525000008/xslF345X05/wk-form4_1758057358.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved